KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Working Capital Changes (2020 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Other Working Capital Changes for 6 consecutive years, with -$4.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 292.2% year-over-year to -$4.6 million, compared with a TTM value of -$5.5 million through Dec 2025, down 401.09%, and an annual FY2025 reading of -$5.5 million, down 401.09% over the prior year.
  • Other Working Capital Changes was -$4.6 million for Q4 2025 at Aurinia Pharmaceuticals, down from $4.2 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $6.0 million in Q3 2021 and bottomed at -$7.3 million in Q4 2023.
  • Average Other Working Capital Changes over 5 years is -$284150.0, with a median of -$25500.0 recorded in 2022.
  • The sharpest move saw Other Working Capital Changes soared 6910.42% in 2023, then crashed 201000.0% in 2025.
  • Year by year, Other Working Capital Changes stood at -$6.5 million in 2021, then soared by 145.18% to $3.0 million in 2022, then crashed by 346.63% to -$7.3 million in 2023, then surged by 132.71% to $2.4 million in 2024, then crashed by 292.2% to -$4.6 million in 2025.
  • Business Quant data shows Other Working Capital Changes for AUPH at -$4.6 million in Q4 2025, $4.2 million in Q3 2025, and $927000.0 in Q2 2025.